Literature DB >> 17090687

Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?

Massimo Cristofanilli1, John Mendelsohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17090687      PMCID： PMC1859890          DOI： 10.1073/pnas.0608651103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  The new cytogenetics: blurring the boundaries with molecular biology.

Authors:  Michael R Speicher; Nigel P Carter
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

Review 2.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

3.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Authors:  Massimo Cristofanilli; Daniel F Hayes; G Thomas Budd; Mathew J Ellis; Alison Stopeck; James M Reuben; Gerald V Doyle; Jeri Matera; W Jeffrey Allard; M Craig Miller; Herbert A Fritsche; Gabriel N Hortobagyi; Leon W M M Terstappen
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

4.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

5.  Circulating tumor cells in patients with breast cancer dormancy.

Authors:  Songdong Meng; Debasish Tripathy; Eugene P Frenkel; Sanjay Shete; Elizabeth Z Naftalis; James F Huth; Peter D Beitsch; Marilyn Leitch; Susan Hoover; David Euhus; Barbara Haley; Larry Morrison; Timothy P Fleming; Dorothee Herlyn; Leon W M M Terstappen; Tanja Fehm; Thomas F Tucker; Nancy Lane; Jianqiang Wang; Jonathan W Uhr
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

8.  HER-2 gene amplification can be acquired as breast cancer progresses.

Authors:  Songdong Meng; Debasish Tripathy; Sanjay Shete; Raheela Ashfaq; Barbara Haley; Steve Perkins; Peter Beitsch; Amanullah Khan; David Euhus; Cynthia Osborne; Eugene Frenkel; Susan Hoover; Marilyn Leitch; Edward Clifford; Ellen Vitetta; Larry Morrison; Dorothee Herlyn; Leon W M M Terstappen; Timothy Fleming; Tanja Fehm; Thomas Tucker; Nancy Lane; Jianqiang Wang; Jonathan Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-11       Impact factor: 11.205

9.  Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.

Authors:  B Naume; E Borgen; S Tøssvik; N Pavlak; D Oates; J M Nesland
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

10.  Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Authors:  Stephen G O'Brien; François Guilhot; Richard A Larson; Insa Gathmann; Michele Baccarani; Francisco Cervantes; Jan J Cornelissen; Thomas Fischer; Andreas Hochhaus; Timothy Hughes; Klaus Lechner; Johan L Nielsen; Philippe Rousselot; Josy Reiffers; Giuseppe Saglio; John Shepherd; Bengt Simonsson; Alois Gratwohl; John M Goldman; Hagop Kantarjian; Kerry Taylor; Gregor Verhoef; Ann E Bolton; Renaud Capdeville; Brian J Druker
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245
View more
  19 in total

1.  Molecular profiling of individual tumor cells by hyperspectral microscopic imaging.

Authors:  Jonathan W Uhr; Michael L Huebschman; Eugene P Frenkel; Nancy L Lane; Raheela Ashfaq; Huaying Liu; Dipen R Rana; Lawrence Cheng; Alice T Lin; Gareth A Hughes; Xiaojing J Zhang; Harold R Garner
Journal:  Transl Res       Date:  2011-09-03       Impact factor: 7.012

Review 2.  Clinical Relevance of Disseminated Tumor Cells in the Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients.

Authors:  Volkmar Müller; Tanja Fehm; Wolfgang Janni; Gerhard Gebauer; Erich Solomayer; Klaus Pantel
Journal:  Breast Care (Basel)       Date:  2009-09-29       Impact factor: 2.860

3.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood.

Authors:  Siyang Zheng; Henry K Lin; Bo Lu; Anthony Williams; Ram Datar; Richard J Cote; Yu-Chong Tai
Journal:  Biomed Microdevices       Date:  2011-02       Impact factor: 2.838

4.  Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.

Authors:  María Campos; Celia Prior; Fernando Warleta; Isabel Zudaire; Jesús Ruíz-Mora; Raúl Catena; Alfonso Calvo; José J Gaforio
Journal:  J Histochem Cytochem       Date:  2008-04-14       Impact factor: 2.479

5.  Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2009-09-09       Impact factor: 15.419

6.  Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells.

Authors:  Eduardo Reátegui; Nicola Aceto; Eugene J Lim; James P Sullivan; Anne E Jensen; Mahnaz Zeinali; Joseph M Martel; Alexander J Aranyosi; Wei Li; Steven Castleberry; Aditya Bardia; Lecia V Sequist; Daniel A Haber; Shyamala Maheswaran; Paula T Hammond; Mehmet Toner; Shannon L Stott
Journal:  Adv Mater       Date:  2015-01-15       Impact factor: 30.849

7.  Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.

Authors:  Mark Jesus M Magbanua; Eduardo V Sosa; Janet H Scott; Jeff Simko; Colin Collins; Dan Pinkel; Charles J Ryan; John W Park
Journal:  BMC Cancer       Date:  2012-02-28       Impact factor: 4.430

8.  Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients.

Authors:  S C C Wong; S S M Ng; M T Cheung; L Y Luk; C M L Chan; A H K Cheung; V H M Lee; P B S Lai; B B Y Ma; E P Hui; M Y Y Lam; T C C Au; A T C Chan
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

9.  Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.

Authors:  Alison L Allan; Michael Keeney
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

10.  Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR.

Authors:  Yan Yu; Gang Xu; Jingyan Cao; Shi Jin; Yingchun Man; Lihua Shang
Journal:  Oncol Lett       Date:  2013-02-05       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.